ResMed's Trading Volume Surges 34.94% to 3.58 Billion, Securing 272nd Spot in Daily Rankings

On May 15, 2025, ResMed's trading volume reached 3.58 billion, marking a 34.94% increase from the previous day. This surge placed ResMed at the 272nd position in terms of trading volume for the day. The stock price of ResMed (RMD) rose by 0.64%.

ResMed has been named the Official Sleep Partner of the Qatar Airways British & Irish Lions Tour to Australia. This partnership aims to promote sleep health during the tour, which will take place over a six-week period. The tour will feature the Lions squad competing against the Wallabies, Super Rugby Pacific teams, and exhibition sides in six cities across Australia.

As the Official Sleep Partner, ResMed will launch the "Tackle Your Sleep" campaign. This digital and content-focused initiative will feature legendary rugby players and address serious sleep health issues affecting both players and fans. The campaign seeks to raise awareness about the importance of quality sleep for overall health and performance, highlighting how poor sleep can negatively impact mental health, physical health, relationships, and daily performance.

ResMed's Chief Marketing Officer, Katrin Pucknat, emphasized the importance of sleep health and the steps individuals can take to improve their sleep. The partnership with the British & Irish Lions Tour provides an opportunity to raise awareness about the connection between sleep and athletic performance, inspiring fans to prioritize their own sleep health.

Rugby Australia CEO, Phil Waugh, and British & Irish Lions CEO, Ben Calveley, both expressed their enthusiasm for the partnership, noting the significance of quality sleep for both players and fans. The tour will include ten matches, with three Test matches against the Wallabies in Brisbane, Melbourne, and Sydney.